
Heterogeneity suggests that identifying different types of Parkinson disease could improve patient management, the understanding of underlying disease mechanisms, and the development of target-specific therapies.
Heterogeneity suggests that identifying different types of Parkinson disease could improve patient management, the understanding of underlying disease mechanisms, and the development of target-specific therapies.
Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.
A discussion about the benefits of a multidisciplinary evaluation for patients with advanced Parkinson disease who are potential candidates for device-assisted therapy.
Michael J. Soileau, MD, discusses the challenges of starting a device-assisted therapy in patients with advanced Parkinson disease.
An advanced Parkinson disease expert explains how to discuss the different device-assisted therapy options with patients.
A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.
A discussion about when a clinician should consider discussing a device-assisted therapy with a patient with advanced Parkinson disease.
Experts discuss their personal experiences using technology and devices in advanced Parkinson disease management and identify patients that are adequately controlled with therapy.
Considerations of gastroparesis in patients with advanced Parkinson disease.
Experts discuss different strategies to manage concerns relating to advanced Parkinson disease including patient education.
A discussion about how to educate and speak with patients with advanced Parkinson disease.
Michael J. Soileau, MD, discusses how to recognize when a patient has advanced Parkinson disease, what are the initial or relevant signs and symptoms of advanced disease, and how patients shift from early to intermediate and advanced disease.
Joohi Jimenez-Shahed, MD, describes the natural progression of Parkinson disease from the time of diagnosis to advanced disease.
Aristide Merola, MD, PhD, leads a discussion about the burden and impairment on the quality of life for patients with advanced Parkinson disease.
Experts in the field of Parkinson disease kick off a discussion about recognizing and managing the disease by defining advanced Parkinson disease.
Published: August 29th 2025 | Updated: September 2nd 2025
Published: July 28th 2025 | Updated: July 30th 2025
Published: May 14th 2025 | Updated: May 16th 2025
Published: May 12th 2025 | Updated: May 13th 2025
Published: March 27th 2025 | Updated: March 28th 2025
Published: March 4th 2025 | Updated: March 19th 2025